$6.93
2.51% day before yesterday
Nasdaq, Jun 28, 10:05 pm CET
ISIN
US6024961012
Symbol
MDXG
Sector
Industry

MiMedx Group, Inc. Target price 2024 - Analyst rating & recommendation

MiMedx Group, Inc. Classifications & Recommendation:

Buy
100%

MiMedx Group, Inc. Target price

Target price $12.67
Course $6.93
Price potential
Number of estimates 6
6 Analysts have issued a price target MiMedx Group, Inc. 2025 . The average MiMedx Group, Inc. target price is $12.67. This is higher than the current share price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 5 Analysts recommend MiMedx Group, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the MiMedx Group, Inc. share has an average upside potential 2025 of . Most analysts recommend the MiMedx Group, Inc. share at Purchase.

Sales and margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Turnover Million $ 321.48 361.48
20.03% 12.44%
EBITDA margin 12.61% 22.03%
271.71% 74.70%
Net margin 14.69% 12.79%
180.79% 12.90%

6 Analysts have issued a sales forecast MiMedx Group, Inc. 2024 . The average MiMedx Group, Inc. sales estimate is

$361m
unlock
. This is
8.06% higher
unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
$365m 9.20%
unlock
, the lowest is
$359m 7.23%
unlock
.

This results in the following potential growth figures:

Sales forecast

2023 $321m 20.03%
2024
$361m 12.44%
unlock
2025
$406m 12.36%
unlock
2026
$478m 17.67%
unlock
2027
$487m 1.90%
unlock
2028
$554m 13.73%
unlock

3 Analysts have issued an MiMedx Group, Inc. EBITDA forecast 2024. The average MiMedx Group, Inc. EBITDA estimate is

$79.6m
unlock
. This is
61.20% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$81.7m 65.38%
unlock
, the lowest is
$76.0m 53.85%
unlock
.

This results in the following potential growth figures and future EBITDA margins:

EBITDA forecast

2023 $40.5m 306.10%
2024
$79.6m 96.43%
unlock
2025
$89.8m 12.73%
unlock
2026
$108m 19.87%
unlock

EBITDA margin

2023 12.61% 271.71%
2024
22.03% 74.70%
unlock
2025
22.10% 0.32%
unlock
2026
22.51% 1.86%
unlock

6 MiMedx Group, Inc. Analysts have issued a net profit forecast 2024. The average MiMedx Group, Inc. net profit estimate is

$46.2m
unlock
. This is
31.88% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$54.6m 19.56%
unlock
, the lowest is
$38.4m 43.48%
unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 $47.2m 196.97%
2024
$46.2m 2.08%
unlock
2025
$61.2m 32.42%
unlock
2026
$98.9m 61.47%
unlock
2027
$97.4m 1.50%
unlock
2028
$133m 36.37%
unlock

Net margin

2023 14.69% 180.79%
2024
12.79% 12.90%
unlock
2025
15.07% 17.83%
unlock
2026
20.68% 37.23%
unlock
2027
19.99% 3.34%
unlock
2028
23.97% 19.91%
unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Earnings per share $ 0.32 0.31
196.97% 3.13%
P/E ratio 22.12
EV/Sales 2.75

6 Analysts have issued a MiMedx Group, Inc. forecast for earnings per share. The average MiMedx Group, Inc. <a href=/blog/eps>EPS is

$0.31
unlock
. This is
32.61% lower
unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
$0.37 19.57%
unlock
, the lowest is
$0.26 43.48%
unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 $0.32 196.97%
2024
$0.31 3.13%
unlock
2025
$0.42 35.48%
unlock
2026
$0.67 59.52%
unlock
2027
$0.66 1.49%
unlock
2028
$0.90 36.36%
unlock

P/E ratio

Current 14.92 151.77%
2024
22.12 48.26%
unlock
2025
16.70 24.50%
unlock
2026
10.34 38.08%
unlock
2027
10.50 1.55%
unlock
2028
7.70 26.67%
unlock

Based on analysts' sales estimates for 2024, the MiMedx Group, Inc. share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth figures and future valuations:

EV/Sales

Current 2.97 1.02%
2024
2.75 7.43%
unlock
2025
2.45 11.00%
unlock
2026
2.08 15.01%
unlock
2027
2.04 1.87%
unlock
2028
1.79 12.07%
unlock

P/S ratio

Current 3.06 15.08%
2024
2.83 7.46%
unlock
2025
2.52 11.00%
unlock
2026
2.14 15.01%
unlock
2027
2.10 1.87%
unlock
2028
1.85 12.07%
unlock

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now